Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans

10.1186/s13195-015-0137-y

Saved in:
Bibliographic Details
Main Authors: Ling, I.-F, Golde, T.E, Galasko, D.R, Koo, E.H
Other Authors: MEDICINE
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/180902
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-180902
record_format dspace
spelling sg-nus-scholar.10635-1809022024-04-18T03:08:37Z Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans Ling, I.-F Golde, T.E Galasko, D.R Koo, E.H MEDICINE amyloid beta protein amyloid precursor protein gamma secretase gamma secretase inhibitor ibuprofen indometacin nonsteroid antiinflammatory agent placebo sulindac sulfide amyloid beta protein amyloid beta protein[1-40] amyloid beta-protein (1-42) amyloid precursor protein APP protein, human ibuprofen nonsteroid antiinflammatory agent peptide fragment secretase Alzheimer disease animal experiment Article cerebrospinal fluid CHO cell line controlled study degenerative disease drug blood level electrospray female gene mutation human in vitro study in vivo study Macaca fascicularis neuromodulation nonhuman nuclear magnetic resonance primate priority journal protein cleavage risk reduction single drug dose thin layer chromatography adult animal blood Cricetulus dose response genetics male metabolism randomization time factor treatment outcome young adult Adult Amyloid beta-Peptides Amyloid beta-Protein Precursor Amyloid Precursor Protein Secretases Animals Anti-Inflammatory Agents, Non-Steroidal CHO Cells Cricetulus Dose-Response Relationship, Drug Female Humans Ibuprofen Macaca fascicularis Male Peptide Fragments Random Allocation Time Factors Treatment Outcome Young Adult 10.1186/s13195-015-0137-y Alzheimer's Research and Therapy 7 1 55 2020-10-27T05:38:33Z 2020-10-27T05:38:33Z 2015 Article Ling, I.-F, Golde, T.E, Galasko, D.R, Koo, E.H (2015). Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans. Alzheimer's Research and Therapy 7 (1) : 55. ScholarBank@NUS Repository. https://doi.org/10.1186/s13195-015-0137-y 17589193 https://scholarbank.nus.edu.sg/handle/10635/180902 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic amyloid beta protein
amyloid precursor protein
gamma secretase
gamma secretase inhibitor
ibuprofen
indometacin
nonsteroid antiinflammatory agent
placebo
sulindac sulfide
amyloid beta protein
amyloid beta protein[1-40]
amyloid beta-protein (1-42)
amyloid precursor protein
APP protein, human
ibuprofen
nonsteroid antiinflammatory agent
peptide fragment
secretase
Alzheimer disease
animal experiment
Article
cerebrospinal fluid
CHO cell line
controlled study
degenerative disease
drug blood level
electrospray
female
gene mutation
human
in vitro study
in vivo study
Macaca fascicularis
neuromodulation
nonhuman
nuclear magnetic resonance
primate
priority journal
protein cleavage
risk reduction
single drug dose
thin layer chromatography
adult
animal
blood
Cricetulus
dose response
genetics
male
metabolism
randomization
time factor
treatment outcome
young adult
Adult
Amyloid beta-Peptides
Amyloid beta-Protein Precursor
Amyloid Precursor Protein Secretases
Animals
Anti-Inflammatory Agents, Non-Steroidal
CHO Cells
Cricetulus
Dose-Response Relationship, Drug
Female
Humans
Ibuprofen
Macaca fascicularis
Male
Peptide Fragments
Random Allocation
Time Factors
Treatment Outcome
Young Adult
spellingShingle amyloid beta protein
amyloid precursor protein
gamma secretase
gamma secretase inhibitor
ibuprofen
indometacin
nonsteroid antiinflammatory agent
placebo
sulindac sulfide
amyloid beta protein
amyloid beta protein[1-40]
amyloid beta-protein (1-42)
amyloid precursor protein
APP protein, human
ibuprofen
nonsteroid antiinflammatory agent
peptide fragment
secretase
Alzheimer disease
animal experiment
Article
cerebrospinal fluid
CHO cell line
controlled study
degenerative disease
drug blood level
electrospray
female
gene mutation
human
in vitro study
in vivo study
Macaca fascicularis
neuromodulation
nonhuman
nuclear magnetic resonance
primate
priority journal
protein cleavage
risk reduction
single drug dose
thin layer chromatography
adult
animal
blood
Cricetulus
dose response
genetics
male
metabolism
randomization
time factor
treatment outcome
young adult
Adult
Amyloid beta-Peptides
Amyloid beta-Protein Precursor
Amyloid Precursor Protein Secretases
Animals
Anti-Inflammatory Agents, Non-Steroidal
CHO Cells
Cricetulus
Dose-Response Relationship, Drug
Female
Humans
Ibuprofen
Macaca fascicularis
Male
Peptide Fragments
Random Allocation
Time Factors
Treatment Outcome
Young Adult
Ling, I.-F
Golde, T.E
Galasko, D.R
Koo, E.H
Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
description 10.1186/s13195-015-0137-y
author2 MEDICINE
author_facet MEDICINE
Ling, I.-F
Golde, T.E
Galasko, D.R
Koo, E.H
format Article
author Ling, I.-F
Golde, T.E
Galasko, D.R
Koo, E.H
author_sort Ling, I.-F
title Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
title_short Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
title_full Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
title_fullStr Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
title_full_unstemmed Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
title_sort modulation of aβ42 in vivo by γ-secretase modulator in primates and humans
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/180902
_version_ 1800914614388523008